HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Masdeu, J. C. Articles by Visintainer, P. Search for Related Content PubMed PubMed Citation Articles by Masdeu, J. C. Articles by Visintainer, P.

Open-ring imaging sign

Highly specific for atypical brain demyelination

From the Departments of Neurology (Drs. Masdeu, Quinto, and Olivera), Radiology (Drs. Tenner and Leslie), and Quantitative Health Sciences (Dr. Visintainer), New York Medical College (St. Vincent’s Hospital and Westchester Medical Center), Valhalla, NY.

Address correspondence and reprint requests to Dr. Joseph C. Masdeu, Department of Neurology, University of Navarre, Pamplona, Spain 31008; e-mail: masdeu{at}nymc.edu

OBJECTIVE: To test the specificity for demyelination of a new neuroimaging sign: contrast enhancement shaped as an open ring or a crescent circumscribed to the white matter.

BACKGROUND: Brain demyelination can cause ring enhancement mimicking neoplasm or infection on CT or MRI.

METHODS: A MEDLINE search of pathology-proved demyelination yielded 32 illustrated cases of ring-enhancing lesions published between 1981 and 1995. Controls consisted of the same number of published images of neoplasms and infections, pathology proved, and matched by year of publication, and age and gender of the patient. Two neuroradiologists read the images twice independently 1 year apart.

RESULTS: Interrater agreement was good ( = 0.64 and 0.66 for either reading). Test-retest reliability was high ( = 0.75 and 0.74 for either rater). The open-ring sign clearly distinguished demyelinating lesions from neoplasms and infections. For demyelination versus neoplasm or infection, the specificity of the reading by the first neuroradiologist was 93.8 (95% CI, 86 to 98), and that of the second was 84.4 (95% CI, 74 to 92). The likelihood ratio of demyelination versus neoplasm averaged 5.2, and versus infection, 17.2. That is, if the lesions had the same incidence in the population, in the presence of an open-ring sign demyelination would be five times more likely than neoplasm and 17 times more likely than infection. However, given the much higher incidence of neoplasms and infections, these lesions are still frequently responsible for open-ring enhancement.

CONCLUSIONS: The open-ring sign is often present in large, contrast-enhancing demyelinating lesions and helps to differentiate them from neoplasms and infections.

Key words: Brain CT—Brain infection—Brain MR—Brain neoplasms—Brain white matter—CT—Contrast enhancement—MS—Cerebral sclerosis—diffuse

This article has been cited by other articles:

				D. S. Kim, D. G. Na, K. H. Kim, J.-h. Kim, E. Kim, B. L. Yun, and K.-H. Chang Distinguishing Tumefactive Demyelinating Lesions from Glioma or Central Nervous System Lymphoma: Added Value of Unenhanced CT Compared with Conventional Contrast-enhanced MR Imaging Radiology, May 1, 2009; 251(2): 467 - 475. [Abstract] [Full Text] [PDF]

				J. Dastgir and F. J. DiMario Jr Acute Tumefactive Demyelinating Lesions in a Pediatric Patient With Known Diagnosis of Multiple Sclerosis: Review of the Literature and Treatment Proposal J Child Neurol, April 1, 2009; 24(4): 431 - 437. [Abstract] [PDF]

				P. D. Smith, M. J. Cook, N. M. Trost, and M. A. Murphy Teaching NeuroImage: Open-ring imaging sign in a case of tumefactive cerebral demyelination Neurology, December 2, 2008; 71(23): e73 - e73. [Full Text] [PDF]

				D. Riva, L. Chiapparini, B. Pollo, M. R. Balestrini, M. Massimino, and N. Milani A Case of Pediatric Tumefactive Demyelinating Lesion Misdiagnosed and Treated as Glioblastoma J Child Neurol, August 1, 2008; 23(8): 944 - 947. [Abstract] [PDF]

				C. F. Lucchinetti, R. H. Gavrilova, I. Metz, J. E. Parisi, B. W. Scheithauer, S. Weigand, K. Thomsen, J. Mandrekar, A. Altintas, B. J. Erickson, et al. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis Brain, July 1, 2008; 131(7): 1759 - 1775. [Abstract] [Full Text] [PDF]

				R M S CARTER and P M PRETORIUS The use of CT and MRI in the characterization of intracranial mass lesions Imaging, June 1, 2007; 19(2): 173 - 184. [Abstract] [Full Text] [PDF]

				J. G. Smirniotopoulos, F. M. Murphy, E. J. Rushing, J. H. Rees, and J. W. Schroeder From the Archives of the AFIP: Patterns of Contrast Enhancement in the Brain and Meninges RadioGraphics, March 1, 2007; 27(2): 525 - 551. [Abstract] [Full Text] [PDF]

				W. Bruck, K. Neubert, T. Berger, and J. R Weber Clinical, radiological, immunological and pathological findings in inflammatory CNS demyelination-possible markers for an antibody-mediated process Multiple Sclerosis, June 1, 2001; 7(3): 173 - 177. [Abstract] [PDF]